Subscribe To
Moderna to set up mrna vaccine manufacturing facility in kenya
Moderna Inc (NASDAQ: MRNA) would set up a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) v...
March 7, 2022, 12:25 pm
Moderna to set up mrna vaccine manufacturing facility in kenya
Moderna Inc (NASDAQ: MRNA) would set up a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) v...
March 7, 2022, 12:25 pm
Moderna to set up mrna vaccine manufacturing facility in kenya
Moderna Inc (NASDAQ: MRNA) would set up a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) v...
March 7, 2022, 12:25 pm
This 1 innovation could disrupt pfizer and moderna's vaccine supremacy
Intranasal sprays might be more effective than jabs....
March 5, 2022, 10:37 am
This 1 innovation could disrupt pfizer and moderna's vaccine supremacy
Intranasal sprays might be more effective than jabs....
March 5, 2022, 10:37 am
What's next for pfizer, moderna beyond their projected $51 billion in combined covid vaccine sales this year
Market analysts are debating what future Covid vaccine demand will look when Covid becomes an endemic, ...
March 3, 2022, 11:53 am
What's next for pfizer, moderna beyond their projected $51 billion in combined covid vaccine sales this year
Market analysts are debating what future Covid vaccine demand will look when Covid becomes an endemic, ...
March 3, 2022, 11:53 am
What's next for pfizer, moderna beyond their projected $51 billion in combined covid vaccine sales this year
Market analysts are debating what future Covid vaccine demand will look when Covid becomes an endemic, ...
March 3, 2022, 11:53 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Merck kgaa predicts more earnings gains on lab supplies demand
Germany's Merck KGaA said it expected strong earnings growth this year, driven by its Life Science unit, which supplies materials and gear to COVID-19...
March 3, 2022, 1:25 am
Merck kgaa predicts more earnings gains on lab supplies demand
Germany's Merck KGaA said it expected strong earnings growth this year, driven by its Life Science unit, which supplies materials and gear to COVID-19...
March 3, 2022, 1:25 am
Merck kgaa predicts more earnings gains on lab supplies demand
Germany's Merck KGaA said it expected strong earnings growth this year, driven by its Life Science unit, which supplies materials and gear to COVID-19...
March 3, 2022, 1:25 am
Risk of covid hospitalization 5 times higher with johnson & johnson shot than pfizer
Though less effective than Pfizer's shot, the risk of hospitalization is still significantly higher for unvacc...
March 2, 2022, 11:41 am
Risk of covid hospitalization 5 times higher with johnson & johnson shot than pfizer
Though less effective than Pfizer's shot, the risk of hospitalization is still significantly higher for unvacc...
March 2, 2022, 11:41 am
Risk of covid hospitalization 5 times higher with johnson & johnson shot than pfizer
Though less effective than Pfizer's shot, the risk of hospitalization is still significantly higher for unvacc...
March 2, 2022, 11:41 am
Novavax's revenues will surge this year. is the stock a buy?
Covid-19 vaccine developer Novavax's stock declined by about 7% in after-hours trading on Monday, after...
March 2, 2022, 8:30 am
Novavax's revenues will surge this year. is the stock a buy?
Covid-19 vaccine developer Novavax's stock declined by about 7% in after-hours trading on Monday, after...
March 2, 2022, 8:30 am
Novavax's revenues will surge this year. is the stock a buy?
Covid-19 vaccine developer Novavax's stock declined by about 7% in after-hours trading on Monday, after...
March 2, 2022, 8:30 am